Cargando…
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
Recently it was demonstrated that tumors induce specific changes to the surface of human endothelial cells thereby providing the basis for designing endothelial cell-based vaccines that directly target antigens expressed by the tumor endothelium. The present report extends these studies in vitro by...
Autores principales: | Lokhov, Petr G., Balashova, Elena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066006/ https://www.ncbi.nlm.nih.gov/pubmed/27781211 http://dx.doi.org/10.1155/2016/5031529 |
Ejemplares similares
-
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2017) -
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
por: Lokhov, Petr G, et al.
Publicado: (2015) -
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
por: Lokhov, Petr G., et al.
Publicado: (2022) -
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021) -
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010)